gstar28 legit
Chargers’ RB room gets thin: Gus Edwards out, J.K. Dobbins questionable
CG Oncology, Inc. ( NASDAQ:CGON – Get Free Report ) shot up 2.5% during mid-day trading on Friday . The stock traded as high as $29.90 and last traded at $29.85. 328,509 shares were traded during mid-day trading, a decline of 51% from the average session volume of 667,276 shares. The stock had previously closed at $29.11. Wall Street Analyst Weigh In Several research firms have recently issued reports on CGON. Bank of America reaffirmed a “buy” rating and set a $65.00 price target on shares of CG Oncology in a research note on Tuesday, October 8th. HC Wainwright reaffirmed a “buy” rating and set a $75.00 target price on shares of CG Oncology in a report on Friday, December 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $66.00 price target on shares of CG Oncology in a research note on Friday, December 6th. Finally, UBS Group assumed coverage on CG Oncology in a research note on Thursday, October 24th. They issued a “buy” rating and a $60.00 price objective on the stock. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $63.88. View Our Latest Report on CGON CG Oncology Stock Performance CG Oncology ( NASDAQ:CGON – Get Free Report ) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.06. The firm had revenue of $0.04 million for the quarter, compared to analysts’ expectations of $0.30 million. CG Oncology had a negative return on equity of 18.97% and a negative net margin of 10,642.98%. On average, research analysts forecast that CG Oncology, Inc. will post -1.32 earnings per share for the current year. Insider Buying and Selling In related news, Director Leonard E. Post sold 1,000 shares of the business’s stock in a transaction dated Friday, December 6th. The stock was sold at an average price of $34.54, for a total value of $34,540.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink . Also, Director Hong Fang Song sold 700,000 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $28.00, for a total value of $19,600,000.00. Following the transaction, the director now directly owns 3,003,931 shares in the company, valued at approximately $84,110,068. This trade represents a 18.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Institutional Investors Weigh In On CG Oncology A number of hedge funds have recently added to or reduced their stakes in CGON. Amalgamated Bank raised its position in shares of CG Oncology by 107.6% during the third quarter. Amalgamated Bank now owns 1,621 shares of the company’s stock worth $61,000 after purchasing an additional 840 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in CG Oncology during the 3rd quarter valued at $241,000. Profund Advisors LLC acquired a new position in CG Oncology during the second quarter worth $300,000. HighVista Strategies LLC bought a new position in shares of CG Oncology in the third quarter valued at $594,000. Finally, M&T Bank Corp grew its holdings in shares of CG Oncology by 55.7% during the third quarter. M&T Bank Corp now owns 16,758 shares of the company’s stock valued at $632,000 after buying an additional 5,996 shares during the last quarter. Institutional investors and hedge funds own 26.56% of the company’s stock. CG Oncology Company Profile ( Get Free Report ) CG Oncology, Inc, an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. Featured Articles Receive News & Ratings for CG Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CG Oncology and related companies with MarketBeat.com's FREE daily email newsletter .
Jimmy Carter, a one-term president who became a globe-trotting elder statesman, dies at 100
BingEx Limited ( NASDAQ:FLX – Get Free Report ) was up 3.4% during mid-day trading on Friday . The company traded as high as $8.20 and last traded at $8.20. Approximately 5,068 shares changed hands during trading, a decline of 90% from the average daily volume of 51,146 shares. The stock had previously closed at $7.93. BingEx Trading Up 2.9 % The stock has a fifty day moving average of $10.08. About BingEx ( Get Free Report ) BingEx Limited, through its subsidiaries, provides on-demand courier services under the FlashEx brand name in the People’s Republic of China. The company offers Flash-Riders as service providers. It serves individual and business customers, including local retailers, restaurants, and logistics players through its mobile platform and website. Featured Stories Receive News & Ratings for BingEx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BingEx and related companies with MarketBeat.com's FREE daily email newsletter .
Tories accuse Labour of waging 'war on rural England' after Angela Rayner announced plans to expand 'London sprawl' across the UK green beltAP Business SummaryBrief at 6:11 p.m. EST
Christmas market opens for 2024 holiday season at Lansdowne ParkWASHINGTON, Dec. 2, 2024 /PRNewswire/ -- NASA and its international partners are set to receive scientific research samples and hardware as a SpaceX Dragon spacecraft departs the International Space Station on Thursday, Dec. 5, for its return to Earth. NASA's live coverage of undocking and departure begins at 10:50 a.m. EST on . Learn how to through a variety of platforms, including social media. The Dragon spacecraft will undock from the forward port of the space station's Harmony module at 11:05 a.m., and fire its thrusters to move a safe distance away from the station after receiving a command from ground controllers at SpaceX. After re-entering Earth's atmosphere, the spacecraft will splash down off the coast of Florida. NASA will not stream the splashdown and will post updates on the agency's blog. Filled with nearly 6,000 pounds of crew supplies, science investigations, and equipment, the spacecraft arrived to the orbiting laboratory Nov. 5 after it launched Nov. 4 on a Falcon 9 rocket from Launch Complex 39A at NASA's Kennedy Space Center in Florida for the agency's SpaceX 31st commercial resupply services mission. Dragon will carry back to Earth thousands of pounds of supplies and scientific experiments designed to take advantage of the space station's microgravity environment. Splashing down off the coast of Florida enables quick transportation of the experiments to NASA's Space Systems Processing Facility at Kennedy Space Center, allowing researchers to collect data with minimal sample exposure to Earth's gravity. Scientific hardware and samples returning to Earth include (Genes in Space Molecular Operations and Sequencing), which successfully conducted in-orbit sequencing of microbial DNA from the space station water system, and marks the first real look at the microbial population of the water system. In addition, (Space Tissue Equivalent Dosimeter) returns to Earth after collecting data on crew radiation exposure and characterizes the space radiation environment. The dosimeter is a student-developed technology demonstration and effectively operated for 11 months on station – six months longer than intended because of its success. Additionally, two specimens printed with ESA's (European Space Agency) , will go to researchers for post-processing and analysis. Researchers will compare the specimens printed in microgravity with those printed on Earth. The goal is to demonstrate the capability to perform metal deposition, or the layering of metals, in 3D under sustained microgravity conditions and manufacture test specimens. Researchers aim to understand the performance and limitations of the chosen technology and become familiar with crewed and remote operations of the instrument onboard a space habitat. Also returning on spacecraft is the , which invited students and educators around the world to submit drawings, paintings, or poems. Winning art submissions were printed on station, photographed in the cupola, and will be returned to their creators on Earth. In addition, researchers will observe high-speed video of bubble behavior in microgravity to understand fundamental processes that occur on a heated bubble surface. Results may improve understanding of how molecules are deposited on bubble surfaces and enhance detection methods for health care and environmental industries. For more than two decades, people have lived and worked continuously aboard the International Space Station, advancing scientific knowledge, and making research breakthroughs that are not possible on Earth. The station is a critical testbed for NASA to understand and overcome the challenges of long-duration spaceflight and to expand commercial opportunities in low Earth orbit. As commercial companies focus on providing human space transportation services and destinations as part of a robust , NASA is focusing more resources on deep space missions to the Moon as part of its Artemis campaign in preparation for future human missions to Mars. Get breaking news, images and features from the space station on , , and . Learn more about the International Space Station at: View original content to download multimedia: SOURCE NASA
NEW YORK (AP) — Top-ranked chess player Magnus Carlsen is headed back to the World Blitz Championship on Monday after its governing body agreed to loosen a dress code that got him fined and denied a late-round game in another tournament for refusing to change out of jeans . Lamenting the contretemps, International Chess Federation President Arkady Dvorkovich said in a statement Sunday that he'd let World Blitz Championship tournament officials consider allowing “appropriate jeans” with a jacket, and other “elegant minor deviations” from the dress code. He said Carlsen's stand — which culminated in his quitting the tournament Friday — highlighted a need for more discussion “to ensure that our rules and their application reflect the evolving nature of chess as a global and accessible sport.” Carlsen, meanwhile, said in a video posted Sunday on social media that he would play — and wear jeans — in the World Blitz Championship when it begins Monday. “I think the situation was badly mishandled on their side,” the 34-year-old Norwegian grandmaster said. But he added that he loves playing blitz — a fast-paced form of chess — and wanted fans to be able to watch, and that he was encouraged by his discussions with the federation after Friday's showdown. “I think we sort of all want the same thing,” he suggested in the video on his Take Take Take chess app’s YouTube channel. “We want the players to be comfortable, sure, but also relatively presentable.” The events began when Carlsen wore jeans and a sportcoat Friday to the Rapid World Championship, which is separate from but held in conjunction with the blitz event. The chess federation said Friday that longstanding rules prohibit jeans at those tournaments, and players are lodged nearby to make sartorial switch-ups easy if needed. An official fined Carlsen $200 and asked him to change pants, but he refused and wasn't paired for a ninth-round game, the federation said at the time. The organization noted that another grandmaster, Ian Nepomniachtchi, was fined earlier in the day for wearing sports shoes, changed and continued to play. Carlsen has said that he offered to wear something else the next day, but officials were unyielding. He said “it became a bit of a matter of principle,” so he quit the rapid and blitz championships. In the video posted Sunday, he questioned whether he had indeed broken a rule and said changing clothes would have needlessly interrupted his concentration between games. He called the punishment “unbelievably harsh.” “Of course, I could have changed. Obviously, I didn’t want to,” he said, and “I stand by that.”
Rivian ranked last for reliability in Consumer Reports survey, while EVs improve overallWomen more likely to need walking aids but less likely to use them – study
Editorial: Legislation to keep kids safe online cannot waitTexans WR Nico Collins says he was fined for tossing TD ball to kid
Don’t rely soley on AI marketing in 2025 for direct hotel sales warns MiraiCowboys opt to shut down Lamb for rest of year
And single people are more likely to use mobility tools compared to those who are married, according to researchers from University College London (UCL) and the London School of Hygiene and Tropical Medicine (LSHTM). Researchers looked at information from a group of more than 12,000 adults in England aged 50 to 89 who were tracked over a 13-year period. At the start of the study, 8,225 adults had no mobility difficulty and did not use mobility assistive products (MAPs). Some 2,480 were deemed to have “unmet need” and 1,375 were using mobility aids. During the follow-up period, there were 2,313 “transitions” where people went from having no mobility issues to needing some help with getting around. And 1,274 people started to use mobility aids. Compared with men, women were 49% more likely to transition from not needing mobility aids to needing to use them, according to the study which has been published in The Lancet Public Health. But were 21% less likely to go on to use mobility aids when they needed them. The authors said their study showed “barriers to access” for women. For both men and women, with every year that passed during the study period the need for mobility aids increased. People who were older, less educated, less wealthy or reported being disabled were more likely to “transition from no need to unmet need, and from unmet need to use”, the authors said, with this indicating a “higher prevalence of mobility limitations and MAP need overall among these groups”. They added: “Finally, marital or partnership status was not associated with transitioning to unmet need; however, single people were more likely to transition from unmet need to use compared with married or partnered people.” Jamie Danemayer, first author of the study from UCL Computer Science and UCL’s Global Disability Innovation Hub, said: “Our analysis suggests that there is a clear gender gap in access to mobility aids. “Though our data didn’t ascertain the reason why participants weren’t using mobility aids, other research tells us that women are often more likely than men to face obstacles such as cost barriers as a result of well-documented income disparities between genders. “Many mobility aids are designed for men rather than women, which we think may be a factor. “Using mobility aids can also make a disability visible, which can impact the safety and stigma experienced by women, in particular. “There’s a critical need for further research to identify and break down the barriers preventing women from accessing mobility aids that would improve their quality of life.” Professor Cathy Holloway, also from UCL, added: “Not having access to mobility aids when a person needs one can have a big impact on their independence, well-being and quality of life. “Our analysis suggests that women, in particular, regardless of other factors such as education and employment status, are not getting the support that they need.” Professor Shereen Hussein, senior author of the study and lead of the social care group at the London School of Hygiene & Tropical Medicine, said: “The research provides compelling evidence of gender disparities in accessing assistive technology, suggesting that cost, design bias, and social stigma are likely to disproportionally affect women. “This underscores the need for inclusive, gender-sensitive approaches in the design, production and inclusivity of assistive technologies.”